Researchers found that calculations for predicting appropriate dosing levels of vancomycin for adults with multidrug-resistant Staphylococcus aureus infections were inaccurate for computing the minimum effective dosages for adolescents between ages 10 and 18. The findings appear in the Journal of Clinical Pharmacology.
Antibiotic dosing calculations appear inaccurate for pediatric MRSA infections
SmartBrief Job Listings for Health Care
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
Meridian Health Plan